These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20195172)

  • 1. Clinical prescribing (and off-label use) in a second-best world.
    Alexander GC
    Med Care; 2010 Apr; 48(4):285-7. PubMed ID: 20195172
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Off-label' prescribing, the Physician's Desk Reference and the court.
    Spector RA; Marquez E
    J La State Med Soc; 2011; 163(5):276-80. PubMed ID: 22272550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care policy. Reforming off-label promotion to enhance orphan disease treatment.
    Liang BA; Mackey T
    Science; 2010 Jan; 327(5963):273-4. PubMed ID: 20075234
    [No Abstract]   [Full Text] [Related]  

  • 4. Off-label use of drugs in children.
    Frattarelli DA; Galinkin JL; Green TP; Johnson TD; Neville KA; Paul IM; Van Den Anker JN;
    Pediatrics; 2014 Mar; 133(3):563-7. PubMed ID: 24567009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label use of drugs and medical devices: a review of policy implications.
    Stafford RS
    Clin Pharmacol Ther; 2012 May; 91(5):920-5. PubMed ID: 22472990
    [No Abstract]   [Full Text] [Related]  

  • 6. Off-label marketing: free speech or illegal promotion?
    Silverman E
    BMJ; 2013 Jan; 346():f320. PubMed ID: 23341546
    [No Abstract]   [Full Text] [Related]  

  • 7. Criminalizing knowledge: the perverse implications of the intended use regulations of off-label promotion prosecutions.
    Gentry G
    Food Drug Law J; 2009; 64(3):441-58. PubMed ID: 19999637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When true enough is not good enough.
    Nat Med; 2013 Jan; 19(1):1. PubMed ID: 23295988
    [No Abstract]   [Full Text] [Related]  

  • 9. Bad to the bone.
    Kimes M
    Fortune; 2012 Oct; 166(6):140-52, 154. PubMed ID: 23072076
    [No Abstract]   [Full Text] [Related]  

  • 10. Lawsuit challenges FDA's authority to prevent off-label marketing.
    Dyer O
    BMJ; 2015 May; 350():h2587. PubMed ID: 25985341
    [No Abstract]   [Full Text] [Related]  

  • 11. US Food and Drug Administration-approved laboratory tests after Caronia.
    Allen TC
    Arch Pathol Lab Med; 2013 Nov; 137(11):1543-4. PubMed ID: 23495756
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From off-label prescribing towards a new FDA.
    Tabarrok A
    Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-Label Prescribing and Polypharmacy: Minimizing the Risks.
    Leahy LG
    J Psychosoc Nurs Ment Health Serv; 2017 Feb; 55(2):17-22. PubMed ID: 28218925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trying to Sidestep Off-Label Dance-Around.
    Kirkner RM
    Manag Care; 2018 Jul; 27(7):6-7. PubMed ID: 29989890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going?
    Joseph JN; Deaton D; Ehsan H; Bonanno MA
    J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing optimal drug therapy for older people: sending the right message: comment on "impact of FDA black box advisory on antipsychotic medication use".
    Rochon PA; Anderson GM
    Arch Intern Med; 2010 Jan; 170(1):103-6. PubMed ID: 20065206
    [No Abstract]   [Full Text] [Related]  

  • 18. Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads.
    Kim J; Kapczynski A
    JAMA Intern Med; 2017 Feb; 177(2):157-158. PubMed ID: 27820607
    [No Abstract]   [Full Text] [Related]  

  • 19. Promotion of off-label use not always a crime.
    Thompson CA
    Am J Health Syst Pharm; 2013 Mar; 70(6):478, 480. PubMed ID: 23456398
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive outcomes through the appropriate use of off-label prescribing.
    Bright JL
    Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.